Quick Answer
Bio Green Med Solution, Inc. reported Total Revenue of $0.00 for fiscal year 2017.
Bio Green Med Solution, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | — |
| Net Income | -$3.00M +73.3% |
-$11.21M +50.3% |
-$22.55M -6.4% |
-$21.20M -12.2% |
-$18.89M -123.6% |
-$8.45M -7.9% |
| Diluted EPS | -$6.45 +98.7% |
-$502.46 -1778.4% |
-$26.75 +1.8% |
-$27.24 -1172.9% |
-$2.14 +37.4% |
-$3.42 |
| Total Assets | $8.19M +99.9% |
$4.09M -53.5% |
$8.80M -68.6% |
$28.05M -34.1% |
$42.59M +15.7% |
$36.80M +140.4% |
| Cash and Equivalents | $3.50M +11.7% |
$3.14M -7.1% |
$3.38M -81.6% |
$18.34M -49.8% |
$36.56M +9.4% |
$33.41M +181.1% |
| Stockholders Equity | $6.84M +414.7% |
-$2.17M -458.2% |
$607.0K -96.2% |
$15.94M -57.7% |
$37.69M +13.3% |
$33.26M +184.3% |
| R&D Expense | $848.0K -87.3% |
$6.66M -65.3% |
$19.16M -5.5% |
$20.27M +31.0% |
$15.48M +225.2% |
$4.76M +2.2% |
| Operating Income | -$8.43M +29.8% |
-$12.00M +52.8% |
-$25.45M +8.0% |
-$27.66M -20.6% |
-$22.94M -115.7% |
-$10.64M -9.9% |
| Shares Outstanding | 5.40M +14529.9% |
36,913 -96.5% |
1.06M +68.6% |
628,139 -93.7% |
9.99M +60.0% |
6.25M +626.4% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | March 31, 2018 | $0.00 | — | — |
| Net Income | September 30, 2025 | -$988.0K | +49.5% | +25.0% |
| Diluted EPS | September 30, 2025 | -$1.31 | +97.0% | -33.7% |
| Total Assets | September 30, 2025 | $8.16M | +51.6% | +85.4% |
| Cash and Equivalents | September 30, 2025 | $3.84M | +28.7% | -10.2% |
| Stockholders Equity | September 30, 2025 | $7.10M | +831.5% | +95.4% |
| R&D Expense | September 30, 2025 | $5.0K | -99.5% | -92.6% |
| Operating Income | September 30, 2025 | -$992.0K | +54.4% | +24.7% |
| Shares Outstanding | September 30, 2025 | 3.50M | +62.5% | +120.8% |
- Bio Green Med Solution, Inc. reported Total Revenue of $0.00 for fiscal year 2017.
- Bio Green Med Solution, Inc. showed a decrease of -100.0% in Total Revenue compared to the prior fiscal year.
- Bio Green Med Solution, Inc. reported Net Income of -$3.00 million for fiscal year 2025.
- Bio Green Med Solution, Inc. showed an increase of +73.3% in Net Income compared to the prior fiscal year.
- Bio Green Med Solution, Inc. reported Diluted EPS of $6.45 per share (loss) for fiscal year 2025.
- Bio Green Med Solution, Inc. showed an increase of +98.7% in Diluted EPS compared to the prior fiscal year.
- Bio Green Med Solution, Inc. reported Total Assets of $8.19 million for fiscal year 2025.
- Bio Green Med Solution, Inc. showed an increase of +99.9% in Total Assets compared to the prior fiscal year.
- Bio Green Med Solution, Inc. reported Cash and Equivalents of $3.50 million for fiscal year 2025.
- Bio Green Med Solution, Inc. showed an increase of +11.7% in Cash and Equivalents compared to the prior fiscal year.
- Bio Green Med Solution, Inc. reported Stockholders Equity of $6.84 million for fiscal year 2025.
- Bio Green Med Solution, Inc. showed an increase of +414.7% in Stockholders Equity compared to the prior fiscal year.
- Bio Green Med Solution, Inc. reported R&D Expense of $848.0 thousand for fiscal year 2025.
- Bio Green Med Solution, Inc. showed a decrease of -87.3% in R&D Expense compared to the prior fiscal year.
- Bio Green Med Solution, Inc. reported Operating Income of -$8.43 million for fiscal year 2025.
- Bio Green Med Solution, Inc. showed an increase of +29.8% in Operating Income compared to the prior fiscal year.
- Bio Green Med Solution, Inc. reported Shares Outstanding of 5.40 million shares for fiscal year 2025.
- Bio Green Med Solution, Inc. showed an increase of +14529.9% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: